Christopher Downs
2019
In 2019, Christopher Downs earned a total compensation of $1.2M as Chief Financial Officer at CNS Pharmaceuticals.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Option Awards | $1,085,708 |
| Salary | $40,000 |
| Other | $3,407 |
| Total | $1,154,115 |
Downs received $1.1M in option awards, accounting for 94% of the total pay in 2019.
Downs also received $25K in bonus, $40K in salary and $3.4K in other compensation.
Rankings
In 2019, Christopher Downs' compensation ranked 8,615th out of 13,971 executives tracked by ExecPay. In other words, Downs earned more than 38.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,615 out of 13,971 | 38th |
Division Manufacturing | 3,419 out of 5,692 | 40th |
Major group Chemicals And Allied Products | 1,294 out of 2,189 | 41st |
Industry group Drugs | 1,100 out of 1,875 | 41st |
Industry Pharmaceutical Preparations | 816 out of 1,387 | 41st |
Source: SEC filing on June 7, 2021.
Downs' colleagues
We found two more compensation records of executives who worked with Christopher Downs at CNS Pharmaceuticals in 2019.